Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
TFPI2 encodes a member of the Kunitz-type serine proteinase inhibitor family. Zusätzlich bieten wir Ihnen TFPI2 Kits (39) und TFPI2 Proteine (28) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 131 products:
Human Polyclonal TFPI2 Primary Antibody für IHC, WB - ABIN2787607
Becker, Volland, Noskova, Schramm, Schweigerer, Wilting: Keratoepithelin reverts the suppression of tissue factor pathway inhibitor 2 by MYCN in human neuroblastoma: a mechanism to inhibit invasion. in International journal of oncology 2007
Human Polyclonal TFPI2 Primary Antibody für IF (p), IHC (p) - ABIN738306
Wang, Wang, Li, Li, Deng: Expression of tissue factor pathway inhibitor-2 in gastric stromal tumor and its clinical significance. in Experimental and therapeutic medicine 2014
our research indicated that miR (zeige MLXIP Antikörper)-130a functions as an oncogene (zeige RAB1A Antikörper) by targeting TFPI2, miR (zeige MLXIP Antikörper)-130a inhibition reduced the growth and angiogenesis of hemangioma by inactivating the FAK (zeige PTK2 Antikörper)/PI3K (zeige PIK3CA Antikörper)/Rac1/mdm2 (zeige MDM2 Antikörper) pathway
TFPI-2 expression was decreased in bladder cancer. TFPI-2 expression was decreased with progression in tumor grade and stage and was correlated to decreased apoptosis.
TFPI2 is a useful serum biomarker for preoperative clinical diagnosis of CCC.
This TPR-dependent PP5 inhibition shown by Ro 90-7501 is a unique and novel inhibitory mechanism, which might be a useful tool for studies of PP5 on both regulatory mechanism and drug discovery.
Over-expression of TFPI-2 and aberrant promoter methylation status presented in the preeclampsia placentas, suggesting that epigenetic mechanism might contribute to the pathogenesis of preeclampsia.
Data show that silencing tumor-endothelial cells (EC) for trypsinogen 4 (zeige PRSS3 Antikörper) accumulated tissue factor pathway inhibitor-2 (TFPI-2) in the matrix.
Hypermethylation of TFPI2 promoter is increased in inflamed colon tissue.
DNA methylation of TFPI2 may play an important role in the carcinogenesis of cervical cancer and that the differential methylation of TFPI2 may at least partially explain the disparity in cervical cancer incidence between Uygur and Han women.
our findings suggested that the differential expression of MMP-2 (zeige MMP2 Antikörper) and TFPI-2 have a negative correlation in pancreatic carcinoma
Our finding suggests that the decreased expression of TFPI-2 may play an important role in the carcinogenesis and progression, and may become a new adjunct marker in the diagnosis and prognosis in cholangiocarcinoma
A novel mouse model is presented and can be used to investigate the role of TFPI-2 in the process of atherosclerosis.
Over-expression of TFPI-2 promotes atherosclerotic plaque stability, which may be related to inhibition of matrix metalloproteinases.
Bovine TFPI2 was compared to mouse TFPI2.
human and murine TFPI-2 have different functions in liver regulation during inflammation in the two species
Our data suggest that TFPI-2 may be an important regulator of aberrant angiogenesis associated with tumor growth/metastasis, cardiovascular diseases, chronic inflammation, or diabetes.
Deficiency for the histone methyltransferase EHMT2 (zeige EHMT2 Antikörper) or for the Polycomb group protein EED (zeige EED Antikörper), leads to biallelic expression of Tfpi2 in the extra-embryonic lineages, whereas the other genes in the cluster maintain correct imprinting.
Dynamic changes of Tfpi2 associated with Il-1beta (zeige IL1B Antikörper) and Tnf-alpha (zeige TNF Antikörper) in the development of acute lung injury are reported.
Bovine TFPI2 was cloned and its expression and characterization determined.
This gene encodes a member of the Kunitz-type serine proteinase inhibitor family. The protein can inhibit a variety of serine proteases including factor VIIa/tissue factor, factor Xa, plasmin, trypsin, chymotryspin and plasma kallikrein. This gene has been identified as a tumor suppressor gene in several types of cancer. Alternative splicing results in multiple transcript variants.
tissue factor pathway inhibitor 2
, tissue factor pathway inhibitor-2
, Tissue factor pathway inhibitor 2
, placental protein 5
, retinal pigment epithelium cell factor 1